Relapsed Lymphomas (DBCOND0042144)

Identifiers

Synonyms

Relapsed Lymphoma

Associated Data

Indicated Drugs and Targets

Drug	Description	Targets
Mitoxantrone	A chemotherapeutic agent used for the treatment of secondary progressive, progressive relapsing, or worsening relapsing-remitting multiple sclerosis.	DNA topoisomerase 2-alphatarget Cytochrome P450 2E1enzyme ATP-dependent translocase ABCB1transporter Multidrug resistance-associated protein 1transporter Broad substrate specificity ATP-binding cassette transporter ABCG2transporter DNAtarget Cytochrome P450 1B1enzyme Cytochrome P450 3A4enzyme DNA topoisomerase 2-betatarget

Clinical Trials

Identifier	Title	Drug(s)	Purpose	Phase	Status
NCT00785798	Vorinostat and Pegylated Liposomal Doxorubicin in Relapsed or Refractory Lymphomas	Doxorubicin Vorinostat	treatment	1 / 2	terminated
NCT01742988	Study to Assess the Safety, Tolerability and Pharmacokinetics of Fimepinostat (CUDC-907) in Patients With Lymphoma	Fimepinostat Rituximab Venetoclax	treatment	1	completed
NCT00054808	Phase II Gallium Nitrate in Relapsed or Refractory Non-Hodgkin's Lymphoma	Gallium nitrate	treatment	2	completed
NCT06563596	Epcoritamab, Zanubrutinib, and Rituximab (EZR) for R/R FL Relapsed or Refractory Follicular Lymphoma	Epcoritamab Rituximab Zanubrutinib	treatment	2	not_yet_recruiting
NCT01929720	Cognitive-Behavioral Intervention for Worry, Uncertainty, and Insomnia for Cancer Survivors	No drug interventions	supportive_care	Not Available	completed